Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase II study evaluating 5-fluorouracil given as a one-hour infusion in combination with calcium leucovorin and interferon alfa-2a in advanced colorectal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Interferon alfa-2a (interferon alfa-2a)
  • Leucovorin calcium (calcium folinate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Neoplasms | Phase 2 | Status: COMPLETED